Benchmark Investment Advisors LLC Makes New $468,000 Investment in McKesson Corporation $MCK

Benchmark Investment Advisors LLC purchased a new stake in McKesson Corporation (NYSE:MCK) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 605 shares of the company’s stock, valued at approximately $468,000.

Other large investors have also added to or reduced their stakes in the company. GGM Financials LLC bought a new position in shares of McKesson in the third quarter worth $25,000. State of Wyoming bought a new stake in McKesson during the second quarter worth about $29,000. Hopwood Financial Services Inc. bought a new stake in McKesson during the third quarter worth about $31,000. Abound Wealth Management grew its stake in McKesson by 104.3% during the third quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after buying an additional 24 shares in the last quarter. Finally, Delos Wealth Advisors LLC bought a new position in McKesson in the 2nd quarter valued at about $35,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares of the company’s stock, valued at approximately $3,214,530. The trade was a 45.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the sale, the executive vice president owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. The trade was a 5.98% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 in the last ninety days. 0.08% of the stock is owned by corporate insiders.

McKesson Stock Down 0.3%

Shares of NYSE:MCK opened at $941.51 on Friday. The stock’s 50 day moving average is $893.90 and its 200-day moving average is $824.34. The firm has a market capitalization of $115.33 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 1.52 and a beta of 0.38. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter last year, the firm earned $8.03 EPS. The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Robert W. Baird set a $968.00 price target on shares of McKesson in a report on Wednesday, January 14th. Wells Fargo & Company lifted their price target on shares of McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. Barclays increased their price target on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research note on Wednesday, February 18th. Finally, TD Cowen increased their target price on McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, McKesson currently has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.